Find all School-related info fast with the new School-Specific MBA Forum

It is currently 19 Aug 2014, 21:03

Close

GMAT Club Daily Prep

Thank you for using the timer - this advanced tool can estimate your performance and suggest more practice questions. We have subscribed you to Daily Prep Questions via email.

Customized
for You

we will pick new questions that match your level based on your Timer History

Track
Your Progress

every week, we’ll send you an estimated GMAT score based on your performance

Practice
Pays

we will pick new questions that match your level based on your Timer History

Not interested in getting valuable practice questions and articles delivered to your email? No problem, unsubscribe here.

Events & Promotions

Events & Promotions in June
Open Detailed Calendar

Pharmaceutical companies typically charge slightly inflated

  Question banks Downloads My Bookmarks Reviews Important topics  
Author Message
TAGS:
Director
Director
avatar
Joined: 18 Jul 2006
Posts: 532
Followers: 1

Kudos [?]: 23 [0], given: 0

GMAT Tests User
Pharmaceutical companies typically charge slightly inflated [#permalink] New post 20 May 2007, 20:04
00:00
A
B
C
D
E

Difficulty:

(N/A)

Question Stats:

0% (00:00) correct 100% (00:00) wrong based on 0 sessions
Pharmaceutical companies typically charge slightly inflated prices for drugs that have a large customer base and are heavily prescribed by doctors to balance the losses such companies experience from producing "orphan" drugs, drugs that are used by so few patients that they can never be profitable. New federal regulations require pharmaceutical companies to limit the price they charge for any drug to cost plus a predetermined percentage profit.

If the statements above are true, which of the following must also be true?

A. New pharmaceutical technology has made advances possible; the drugs produced by such technology, however, are too expensive for all but the most wealthy patients.

B. If pharmaceutical companies do not find another source of income to balance the losses they experience in producing "orphan" drugs, such companies will no longer be able to produce such drugs without compromising overall profits.

C. Some patients already request generic pharmaceuticals, when they are available, because they are typically less expensive than name-brand pharmaceuticals.

D. If pharmaceutical companies reduce the costs of producing most drugs, they will be able to earn more profits despite the new law, and thus will be able to balance the losses they experience from the production of "orphan" drugs.

E. Even though charitable organizations that fund research into the rare diseases treated by "orphan" drugs provide some donations to offset the costs of "orphan" drugs, such donations are declining.
Manager
Manager
avatar
Joined: 02 May 2007
Posts: 155
Followers: 1

Kudos [?]: 5 [0], given: 0

GMAT Tests User
Re: CR - Companies [#permalink] New post 20 May 2007, 20:35
Juaz wrote:
Pharmaceutical companies typically charge slightly inflated prices for drugs that have a large customer base and are heavily prescribed by doctors to balance the losses such companies experience from producing "orphan" drugs, drugs that are used by so few patients that they can never be profitable. New federal regulations require pharmaceutical companies to limit the price they charge for any drug to cost plus a predetermined percentage profit.

If the statements above are true, which of the following must also be true?

A. New pharmaceutical technology has made advances possible; the drugs produced by such technology, however, are too expensive for all but the most wealthy patients.

B. If pharmaceutical companies do not find another source of income to balance the losses they experience in producing "orphan" drugs, such companies will no longer be able to produce such drugs without compromising overall profits.

C. Some patients already request generic pharmaceuticals, when they are available, because they are typically less expensive than name-brand pharmaceuticals.

D. If pharmaceutical companies reduce the costs of producing most drugs, they will be able to earn more profits despite the new law, and thus will be able to balance the losses they experience from the production of "orphan" drugs.

E. Even though charitable organizations that fund research into the rare diseases treated by "orphan" drugs provide some donations to offset the costs of "orphan" drugs, such donations are declining.


For (B)
Manager
Manager
User avatar
Joined: 01 Feb 2007
Posts: 64
Followers: 2

Kudos [?]: 2 [0], given: 0

Reviews Badge
 [#permalink] New post 20 May 2007, 21:19
B.
Senior Manager
Senior Manager
avatar
Joined: 01 Jan 2007
Posts: 327
Followers: 1

Kudos [?]: 17 [0], given: 0

GMAT Tests User
 [#permalink] New post 21 May 2007, 05:20
Down to B & D. But couldn't decide between them. Can somebody explain why B is right and whats wrong with D.

Javed.

Cheers!
Manager
Manager
avatar
Joined: 23 Mar 2007
Posts: 177
Followers: 0

Kudos [?]: 1 [0], given: 0

GMAT Tests User
 [#permalink] New post 21 May 2007, 10:36
another B.

D is incorrect because "reducing the costs of producing most drugs" was an option that was open even before the federal regulations .
Manager
Manager
User avatar
Joined: 16 May 2007
Posts: 145
Followers: 1

Kudos [?]: 7 [0], given: 0

GMAT Tests User
 [#permalink] New post 21 May 2007, 12:18
Straight B
Director
Director
avatar
Joined: 18 Jul 2006
Posts: 532
Followers: 1

Kudos [?]: 23 [0], given: 0

GMAT Tests User
 [#permalink] New post 21 May 2007, 15:12
OA is B.
Intern
Intern
avatar
Joined: 20 May 2007
Posts: 6
Followers: 0

Kudos [?]: 0 [0], given: 0

 [#permalink] New post 21 May 2007, 17:50
Maybe it's just me, but people replying to posts with "A's, B's, C's etc." is helping no one understand why answers are wrong or right.

In a must be true question, you're looking for the following:
(*) Find the proof that supports your answer in the stimulus
(*) Look for the connection between the premises, same words being used

Lets now break down each of the choices:
(A); "New pharmaceutical technology", you see this mentioned no where in the passage, so this one is out right away.

(C); "Some patients already request generic pharmaceticals, when they are avaiable"; again you see this mentioned no where in the passage.

(E); "Even though some charitable organizations", that is all you need to read, as this is not present in the passage.

(D); If pharmaceutical companies reduce the cost of producing "MOST" drugs. In the passage though you see "new federal regulations require pharmaceutical companies to limit the price they chare for ANY drug"
any = all.

Left with B.

Please feel free to correct me if I'm wrong with any of my analysis.

Joe.
Director
Director
avatar
Joined: 24 Aug 2006
Posts: 754
Location: Dallas, Texas
Followers: 5

Kudos [?]: 26 [0], given: 0

GMAT Tests User
 [#permalink] New post 21 May 2007, 21:11
I have never seen such lame options; the question itself is praying "please pick B" :)
_________________

"Education is what remains when one has forgotten everything he learned in school."

Director
Director
avatar
Joined: 29 Jul 2006
Posts: 877
Followers: 3

Kudos [?]: 14 [0], given: 0

GMAT Tests User
 [#permalink] New post 22 May 2007, 10:14
Euclid 315 wrote:
Maybe it's just me, but people replying to posts with "A's, B's, C's etc." is helping no one understand why answers are wrong or right.

In a must be true question, you're looking for the following:
(*) Find the proof that supports your answer in the stimulus
(*) Look for the connection between the premises, same words being used

Lets now break down each of the choices:
(A); "New pharmaceutical technology", you see this mentioned no where in the passage, so this one is out right away.

(C); "Some patients already request generic pharmaceticals, when they are avaiable"; again you see this mentioned no where in the passage.

(E); "Even though some charitable organizations", that is all you need to read, as this is not present in the passage.

(D); If pharmaceutical companies reduce the cost of producing "MOST" drugs. In the passage though you see "new federal regulations require pharmaceutical companies to limit the price they chare for ANY drug"
any = all.

Left with B.

Please feel free to correct me if I'm wrong with any of my analysis.

Joe.


B it is...Good explanation...Keep up the good work!!!
Intern
Intern
avatar
Joined: 19 May 2007
Posts: 30
Followers: 0

Kudos [?]: 2 [0], given: 0

 [#permalink] New post 22 May 2007, 18:59
B

D is not true because if the company reduces cost of producing a drug, it can only get less amount in profit per drug. overall profit cannot increase if its tied to a percentage of cost of production.
Senior Manager
Senior Manager
User avatar
Joined: 01 Feb 2005
Posts: 275
Followers: 1

Kudos [?]: 29 [0], given: 1

GMAT Tests User
 [#permalink] New post 23 May 2007, 01:34
Down to B and D... I was more inclined towards choosing D but I see the word MOST in the answer choice D which is not the same as what the federal regulations demand...!! B makes sense
  [#permalink] 23 May 2007, 01:34
    Similar topics Author Replies Last post
Similar
Topics:
1 Experts publish their posts in the topic Pharmaceutical Companies: Weaken the argument Question vikasbansal227 2 05 Feb 2014, 02:20
4 Experts publish their posts in the topic The pharmaceutical company conceded that its blockbuster Vercules 7 25 Jun 2013, 22:17
2 A director of the Rexx Pharmaceutical Company argued that RaviChandra 6 23 May 2010, 07:05
A pharmaceutical company received $3 million in royalties on Achilless 1 20 Aug 2006, 20:18
A thinly stretched pharmaceuticals company operates three Titleist 16 16 Oct 2005, 17:52
Display posts from previous: Sort by

Pharmaceutical companies typically charge slightly inflated

  Question banks Downloads My Bookmarks Reviews Important topics  


cron

GMAT Club MBA Forum Home| About| Privacy Policy| Terms and Conditions| GMAT Club Rules| Contact| Sitemap

Powered by phpBB © phpBB Group and phpBB SEO

Kindly note that the GMAT® test is a registered trademark of the Graduate Management Admission Council®, and this site has neither been reviewed nor endorsed by GMAC®.